Orient Europharma Co (ROCO:4120) Days Sales Outstanding : 58.00 (As of Jun. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Orient Europharma Co Days Sales Outstanding?

Orient Europharma Co's average Accounts Receivable for the three months ended in Jun. 2024 was NT$690 Mil. Orient Europharma Co's Revenue for the three months ended in Jun. 2024 was NT$1,086 Mil. Hence, Orient Europharma Co's Days Sales Outstanding for the three months ended in Jun. 2024 was 58.00.

The historical rank and industry rank for Orient Europharma Co's Days Sales Outstanding or its related term are showing as below:

ROCO:4120' s Days Sales Outstanding Range Over the Past 10 Years
Min: 37.22 Med: 39.56 Max: 53.71
Current: 53.71

During the past 13 years, Orient Europharma Co's highest Days Sales Outstanding was 53.71. The lowest was 37.22. And the median was 39.56.

ROCO:4120's Days Sales Outstanding is ranked better than
67.55% of 986 companies
in the Drug Manufacturers industry
Industry Median: 71.32 vs ROCO:4120: 53.71

Orient Europharma Co's Days Sales Outstanding increased from Jun. 2023 (50.67) to Jun. 2024 (58.00).

Orient Europharma Co Days Sales Outstanding Historical Data

The historical data trend for Orient Europharma Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orient Europharma Co Days Sales Outstanding Chart

Orient Europharma Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

38.24

37.22

38.75

45.86

52.27

Orient Europharma Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Days Sales Outstanding	Get a 7-Day Free Trial															50.67	52.71	48.63	56.22	58.00

Competitive Comparison of Orient Europharma Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Orient Europharma Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orient Europharma Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orient Europharma Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Orient Europharma Co's Days Sales Outstanding falls into.

Orient Europharma Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Orient Europharma Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (650.947	+	664.343)	/	2 )	/	4591.894	*	365
=	657.645					/	4591.894	*	365
=	52.27

Orient Europharma Co's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

	Days Sales Outstanding (Q: Jun. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2024 )	+	Accounts Receivable (A: Jun. 2024 ))	/	count )	/	Revenue (A: Jun. 2024 )	*	Days in Period
=	( (696.517	+	684.146)	/	2 )	/	1086.067	*	365 / 4
=	690.3315					/	1086.067	*	365 / 4
=	58.00

Orient Europharma Co (ROCO:4120) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Orient Europharma Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Orient Europharma Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Orient Europharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orient Europharma Co Ltd (ROCO:4120) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

13F., No. 128, Chengde Rd., Sec. 6,, Beitou Distrit, Taipei, TWN, 112052

Website

https://www.oep.com.tw

Orient Europharma Co Ltd is a Taiwan-based company engaged in the wholesale of f Western Pharmaceutical and Medical Devices. The firm also Manufacture Drugs and Medicines, Beverages, Cleaning Preparations, Cosmetics, Medical Devices, and Other Food Products. Its products cover various therapeutic areas, including the central nervous system, cardiovascular, diabetes, allergy, cosmetics, and health supplements.

Orient Europharma Co Headlines

No Headlines